International Trade Groups Call For Regulators To Protect Off-Patent Industry From Inflation
Generics Players Could Benefit From Greater Control Over Their Prices In 2023
Rising inflation has exacerbated pressures in the off-patent drug sector, prompting Medicines for Europe and the US Association for Accessible Medicines to call for regulatory intervention to ensure the long-term sustainability of the space.
